Reduced cardiac side-effect potential by introduction of polar groups: discovery of NIBR-1282, an orally bioavailable CCR5 antagonist which is active in vivo. (Q51791405)
Jump to navigation
Jump to search
scientific article published on 2 February 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Reduced cardiac side-effect potential by introduction of polar groups: discovery of NIBR-1282, an orally bioavailable CCR5 antagonist which is active in vivo. |
scientific article published on 2 February 2008 |
Statements
Reduced cardiac side-effect potential by introduction of polar groups: discovery of NIBR-1282, an orally bioavailable CCR5 antagonist which is active in vivo. (English)
1 reference
Gebhard Thoma
1 reference
Christian Beerli
1 reference
Marc Bigaud
1 reference
Christian Bruns
1 reference
Nigel G Cooke
1 reference
Markus B Streiff
1 reference
Hans-Guenter Zerwes
1 reference
2 February 2008
1 reference
18
1 reference
6
1 reference
2000-2005
1 reference